What LSX Ltd does

LSX Ltd operates as a life science executive networking and events brand, run through Informa Connect Limited (a division of publicly-listed Informa PLC, LSE: INF). The company is headquartered in London, United Kingdom, with 11-50 employees and a reported founding year of 2014. Co-founder and CEO is Neil Darkes. Its core product is a portfolio of five flagship annual conferences plus a recurring awards program: Investival Showcase USA (Miami, March), LSX World Congress Europe (Lisbon, March), LSX Nordic Congress (Copenhagen, May), LSX World Congress USA (Boston, September), and Investival Showcase Europe (London, November), together with the European Lifestars Awards (London, November). Across all events LSX layers the partneringONE networking platform, which enables attendees to schedule meetings and build custom agendas to maximize networking time during congresses and showcases.

The business serves senior decision-makers across biotech, healthtech, medtech, and pharmatech verticals, with stated use cases centered on accessing capital, identifying strategic partners, gaining industry insights, and supporting product launches and business development. Customer segmentation is organized vertically into Biotech Leaders, Medtech Leaders, and Pharmatech Leaders sponsorship tracks. Geographic coverage spans North America (USA) and Europe (UK, Portugal, Denmark). Revenue is generated primarily through custom sponsorship packages sold directly to life science companies seeking to increase profile, launch products, or pursue business development, complemented by delegate attendance at paid events. The company is privately held as a brand within Informa PLC's B2B events portfolio, with no independent external investors or separate fundraising. A minor co-branding partnership with Nasdaq is associated with the LSX Nordic Congress.

Name

LSX Ltd

Legal name

Informa Connect Limited

Website

https://lsxleaders.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

LSX Ltd is a London-based life science events brand (part of Informa Connect / Informa PLC) running five flagship annual conferences and the European Lifestars Awards across the US and Europe, serving senior biotech, medtech, and pharmatech executives with networking, capital access, and sponsorship products supported by the partneringONE platform.

Ownership category

akta.pro rank

Product category

Life Science Events and Conferences

NAICS

Management Consulting Services (54161), Software Publishers (513210)

SIC

Services-Management Consulting Services (8742), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Finance & Investment Conferences (MPAGAGAG)

akta.pro secondary industry

Customer Experience (CX) & Digital Experience (BPAHAEAC)

Keywords

• Life science events
• Biotech networking conferences
• Medtech partnering platforms
• Pharmatech investment events
• Executive congresses

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Operations, Marketing or Sales, Personnel, Technology or R&D

Revenue model

1. Event Sponsorship: LSX generates revenue through custom sponsorship packages for life science companies looking to increase their profile, launch new products, or focus on business development opportunities. Sponsors can reach senior decision-makers at flagship biotech, medtech, and pharmatech events.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

LSX Ltd operates a portfolio of in-person conferences, investment showcases, and awards programs targeting senior life science industry decision-makers across biotech, medtech, and pharmatech sectors. The company connects executives with investors, strategic partners, and industry insights through flagship events held across North America and Europe, supported by the partneringONE networking and scheduling platform.

Product overview

LSX Ltd, operating under the Informa Connect division, is a portfolio of life science industry events rather than a single unified software product. The offering consists of six named live-event products organized around two pillars: networking and pitching events (Investival Showcase USA, Investival Showcase Europe) and strategic congresses (LSX World Congress Europe, LSX World Congress USA, LSX Nordic Congress), supplemented by the European Lifestars Awards. These events are supported by the partneringONE platform, which provides the digital scheduling and networking infrastructure used across all event types. Together, the portfolio targets senior biotech, medtech, and pharmatech decision-makers seeking knowledge, capital, and strategic partnerships.

Differentiator

Problem solved

Functional benefit

Products and services

• Investival Showcase USA A two-day biotech, healthtech, and medtech networking and pitching event held in North America, offering companies opportunities to present to investors and connect with industry decision-makers.
• LSX World Congress Europe A flagship European congress connecting senior life science industry decision-makers with knowledge, capital, and strategic partners through panels, keynotes, and networking sessions.
• LSX Nordic Congress A regional congress in Copenhagen focused on simplifying access to capital for life science companies through strategic knowledge sessions and investor partnering.
• LSX World Congress USA A US-based congress focused on partnering, strategy, and investment for life science executive leaders, held in Boston, Massachusetts.
• Investival Showcase Europe A premier biotech, healthtech, and medtech networking and pitching event held annually in London, serving as the European counterpart to the Investival Showcase USA event.
• European Lifestars Awards An awards program celebrating the achievements of pan-European life science executives and their partners, recognizing excellence across the biotech, medtech, and pharmatech sectors.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• NasdaqminorStrategic or Co-development PartnerNasdaq is referenced in connection with the LSX Nordic Congress, specifically noting 'Nasdaq ring the bell at the LSX Nordic Congress' imagery. This suggests a co-branding or presence at the event, potentially for listing or market visibility purposes.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• BioCentury: Provides life science industry intelligence and runs partnering / investment-focused events and webinars for biotech executives and investors. Closely comparable business model combining content, events, and deal-making tools for the same senior life science buyer.
• EBD Group / BIO-Europe: Operates BIO-Europe and BIO-Europe Spring, the largest European biotech partnering events. EBD is also part of Informa, making it the most directly comparable peer — and an internal sibling — to LSX in the life science partnering conference space.
• BioPharm America (EBD Group / Informa): Informa/EBD's flagship US-based biotech partnering event. Directly comparable to LSX World Congress USA and Investival Showcase USA; another internal sibling within Informa's portfolio competing for the same North American biotech executive audience.
• Fierce Biotech / Fierce Pharma Events: Combines life science media with industry events and webinars targeted at biotech and pharma executives. Comparable hybrid content-plus-events model serving the same buyer persona as LSX.
• Sachs Associates: Runs a portfolio of life science investment and partnering conferences (e.g., European Biotech Week, Rare Disease Forum). Directly comparable niche-scale event business serving similar biotech executives and investors across European geographies.

Regional players

• Jefferies Healthcare Conference: Major US-focused healthcare investment conference run by Jefferies, attracting senior biotech executives and institutional investors. Comparable to LSX World Congress USA in attendee profile, with a more US-concentrated and finance-centric emphasis.
• ChinaBio Partnering Forum: One of the largest life science partnering events in Asia, connecting global biotechs with Chinese and Asia-Pacific partners and investors. Comparable in format (investor partnering + pitching) to LSX's Investival Showcases but serving a different geography.

Broad incumbents

• Biotechnology Innovation Organization (BIO): Runs the BIO International Convention, the largest global biotech industry event, and BIO Partnering. Directly competes with LSX for senior biotech executive attention and sponsorship dollars, but at substantially greater scale and a broader trade-association remit.
• J.P. Morgan Healthcare Conference: The flagship annual US healthcare investment conference hosted by J.P. Morgan in San Francisco. Competes with LSX World Congress USA for senior biotech executive time during the January 'Healthcare Week' window and sets the bar for institutional investor attendance.

Emerging players

• MedCity INVEST: Runs healthcare investor conferences focused on digital health, medtech, and emerging therapy areas. Comparable niche event positioning to LSX's medtech and healthtech tracks but with a more digital-health-skewed audience.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lsx-leaders
• Xx.com/LSXLeaders
• Facebookfacebook.com/LSXLeaders

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LSX Ltd